Sg Americas Securities, LLC Crispr Therapeutics Ag Transaction History

Sg Americas Securities, LLC

$27.6 Billion
Q3 2024

A detailed history of Sg Americas Securities, LLC transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Sg Americas Securities, LLC holds 25,711 shares of CRSP stock, worth $1.23 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

25,711

Previous 26,179 1.79%

Holding current value

$1.23 Million

Previous $1.41 Million 14.57%

% of portfolio

0.0%

Previous 0.01%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 03, 2024	SELL	$44.62 - $62.75 $20,882 - $29,367	-468 Reduced 1.79%	25,711 $1.21 Million
Q2 2024 Jul 12, 2024	SELL	$51.17 - $68.18 $646,123 - $860,908	-12,627 Reduced 32.54%	26,179 $1.41 Million
Q1 2024 May 06, 2024	SELL	$60.67 - $89.12 $558,588 - $820,527	-9,207 Reduced 19.18%	38,806 $2.65 Million
Q4 2023 Jan 12, 2024	BUY	$38.62 - $72.18 $959,706 - $1.79 Million	24,850 Added 107.28%	48,013 $3.01 Million
Q3 2023 Oct 13, 2023	SELL	$45.39 - $59.0 $173,299 - $225,262	-3,818 Reduced 14.15%	23,163 $1.05 Million
Q2 2023 Jul 10, 2023	BUY	$43.47 - $67.77 $22,647 - $35,308	521 Added 1.97%	26,981 $1.52 Million
Q1 2023 Apr 28, 2023	SELL	$41.0 - $56.12 $35,793 - $48,992	-873 Reduced 3.19%	26,460 $1.2 Million
Q4 2022 Feb 02, 2023	BUY	$39.19 - $65.67 $567,980 - $951,755	14,493 Added 112.87%	27,333 $1.11 Million
Q3 2022 Oct 31, 2022	SELL	$61.1 - $83.78 $3.08 Million - $4.22 Million	-50,372 Reduced 79.69%	12,840 $839,000
Q2 2022 Jul 29, 2022	BUY	$43.23 - $73.83 $2.54 Million - $4.34 Million	58,765 Added 1321.45%	63,212 $3.84 Million
Q1 2022 Apr 29, 2022	SELL	$53.19 - $79.24 $994,812 - $1.48 Million	-18,703 Reduced 80.79%	4,447 $279,000
Q4 2021 Feb 07, 2022	SELL	$70.09 - $111.29 $3.42 Million - $5.43 Million	-48,806 Reduced 67.83%	23,150 $1.75 Million
Q3 2021 Nov 01, 2021	BUY	$110.2 - $156.64 $1.24 Million - $1.76 Million	11,234 Added 18.5%	71,956 $8.05 Million
Q2 2021 Aug 12, 2021	BUY	$100.84 - $161.89 $102,050 - $163,832	1,012 Added 1.69%	60,722 $9.83 Million
Q1 2021 May 13, 2021	BUY	$110.72 - $210.04 $6.02 Million - $11.4 Million	54,346 Added 1013.16%	59,710 $7.28 Million
Q4 2020 Feb 04, 2021	SELL	$79.67 - $173.23 $122,930 - $267,293	-1,543 Reduced 22.34%	5,364 $821,000
Q3 2020 Nov 09, 2020	SELL	$78.5 - $100.64 $114,924 - $147,336	-1,464 Reduced 17.49%	6,907 $578,000
Q2 2020 Jul 20, 2020	BUY	$38.5 - $76.05 $322,283 - $636,614	8,371 New	8,371 $615,000
Q1 2020 Apr 30, 2020	SELL	$33.68 - $62.53 $221,782 - $411,760	-6,585 Closed	0 $0
Q4 2019 Jan 28, 2020	SELL	$36.68 - $73.13 $437,188 - $871,636	-11,919 Reduced 64.41%	6,585 $401,000
Q3 2019 Nov 04, 2019	BUY	$40.99 - $52.56 $758,478 - $972,570	18,504 New	18,504 $758,000

Others Institutions Holding CRSP

# of Institutions

491

Shares Held

58M

Call Options Held

1.1M

Put Options Held

1.9M

View Full List

About CRISPR Therapeutics AG

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $3.74B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

More about CRSP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg Americas Securities, LLC with notifications on news.

Account

Sg Americas Securities, LLC Crispr Therapeutics Ag Transaction History